ArticleOncoscience2022

MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?

Laura Gramantieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.